Polatuzumab is a monoclonal antibody specifically designed to bind to CD79b, a protein expressed on the surface of B cells. This antibody serves as a foundational component for the creation of the antibody-drug conjugate (ADC) Polatuzumab Vedotin, which exhibits potent anti-tumor properties. This targeted approach allows for the direct delivery of cytotoxic agents to malignant cells, thereby enhancing therapeutic efficacy while minimizing off-target effects. Polatuzumab and its derivatives are pivotal in advancing research and treatment options in oncology, particularly in the study and management of hematological malignancies.
Polatuzumab is a monoclonal antibody specifically designed to bind to CD79b, a protein expressed on the surface of B cells. This antibody serves as a foundational component for the creation of the antibody-drug conjugate (ADC) Polatuzumab Vedotin, which exhibits potent anti-tumor properties. This targeted approach allows for the direct delivery of cytotoxic agents to malignant cells, thereby enhancing therapeutic efficacy while minimizing off-target effects. Polatuzumab and its derivatives are pivotal in advancing research and treatment options in oncology, particularly in the study and management of hematological malignancies.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
